EP Medsystems Inc - Current report filing (8-K)

---

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

---

FORM 8-K

 

---

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 1, 2007

 

---

EP MedSystems, Inc

(Exact name of Registrant as Specified in its Charter)

 

---

New Jersey

(State or Other Jurisdiction of Incorporation)

 

0-28260		22-3212190
(Commission File Number)		(IRS Employer Identification No.)

575 Route 73 North, Bldg. D

West Berlin, New Jersey 08091

(Address of Principal Executive Offices and Zip Code)

[phone]

(Registrant’s telephone number, including area code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d 2(b))

 

¨	Pre-commencement communications pursuant to Rule 13e-4(c)under the Exchange Act (17 CFR 240.13e-4(c))

 

---

---

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On November 1, 2007, EP MedSystems, Inc. issued a press release announcing results of operations for the three and nine month periods ending September 30, 2007. The entire text of the press release is furnished as Exhibit 99.1.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

 

(a)

Financial statements: None.

 

(b)

Pro forma financial information: None.

 

(c)

Shell Company Transactions: None.

 

(d)

Exhibits:

 

99.1

Press Release dated November 1, 2007, issued by EP MedSystems, Inc. announcing third quarter results for the three and nine month periods ending September 30, 2007.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

		EP MedSystems, Inc.
		By		/s/ James J. Caruso
Date: November 6, 2007				James J. Caruso
				Chief Financial Officer